advertisement
Yoshikawa K 11
Showing records 1 to 11 | Display all abstracts from Yoshikawa K69466 Relationship between visual field progression and baseline refraction in primary open-angle glaucoma
Naito T
Clinical Ophthalmology 2016; 10: 1397-1403
69287 Effects of Brinzolamide, a Topical Carbonic Anhydrase Inhibitor, on Corneal Endothelial Cells
Nakano T; Inoue R
Advances in Therapy 2016; 33: 1452-1459
69466 Relationship between visual field progression and baseline refraction in primary open-angle glaucoma
Yoshikawa K; Mizoue S
Clinical Ophthalmology 2016; 10: 1397-1403
69287 Effects of Brinzolamide, a Topical Carbonic Anhydrase Inhibitor, on Corneal Endothelial Cells
Kimura T
Advances in Therapy 2016; 33: 1452-1459
69466 Relationship between visual field progression and baseline refraction in primary open-angle glaucoma
Nanno M
Clinical Ophthalmology 2016; 10: 1397-1403
69287 Effects of Brinzolamide, a Topical Carbonic Anhydrase Inhibitor, on Corneal Endothelial Cells
Suzumura H; Tanino T
Advances in Therapy 2016; 33: 1452-1459
69466 Relationship between visual field progression and baseline refraction in primary open-angle glaucoma
Kimura T
Clinical Ophthalmology 2016; 10: 1397-1403
69287 Effects of Brinzolamide, a Topical Carbonic Anhydrase Inhibitor, on Corneal Endothelial Cells
Yamazaki Y
Advances in Therapy 2016; 33: 1452-1459
69466 Relationship between visual field progression and baseline refraction in primary open-angle glaucoma
Suzumura H; Umeda Y
Clinical Ophthalmology 2016; 10: 1397-1403
69287 Effects of Brinzolamide, a Topical Carbonic Anhydrase Inhibitor, on Corneal Endothelial Cells
Yoshikawa K; Tatemichi M
Advances in Therapy 2016; 33: 1452-1459
69466 Relationship between visual field progression and baseline refraction in primary open-angle glaucoma
Shiraga F
Clinical Ophthalmology 2016; 10: 1397-1403
